Crystalline Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Crystalline Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,421	Closed	-$128K	–	158
2022 Q4	$128K	Buy	+11,421	New	+$111K	0.06%	108

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crystalline Management's OYST Position: Q1 2023 in Review

Crystalline Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 11,421 shares — an estimated $128K sold.

Crystalline Management first reported a position in OYST in Q4 2022 and held it in 1 quarter. The position peaked at $128K in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Crystalline Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Crystalline Management sold 11,421 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $128K.
Crystalline Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Crystalline Management's Oyster Point Pharma, Inc. Common Stock position peaked at $128K in Q4 2022.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Crystalline Management's 13F filing for Q1 2023, filed 9 May 2023.